PE20080396A1 - COMPOSITION AND METHOD TO RAISE GLUCOSE LEVEL IN BLOOD - Google Patents
COMPOSITION AND METHOD TO RAISE GLUCOSE LEVEL IN BLOODInfo
- Publication number
- PE20080396A1 PE20080396A1 PE2007000181A PE2007000181A PE20080396A1 PE 20080396 A1 PE20080396 A1 PE 20080396A1 PE 2007000181 A PE2007000181 A PE 2007000181A PE 2007000181 A PE2007000181 A PE 2007000181A PE 20080396 A1 PE20080396 A1 PE 20080396A1
- Authority
- PE
- Peru
- Prior art keywords
- composition
- blood
- acid
- glucose level
- raise glucose
- Prior art date
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract 2
- 239000008103 glucose Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 abstract 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 abstract 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 abstract 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 abstract 1
- 208000013016 Hypoglycemia Diseases 0.000 abstract 1
- 239000005642 Oleic acid Substances 0.000 abstract 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229940119217 chamomile extract Drugs 0.000 abstract 1
- 235000020221 chamomile extract Nutrition 0.000 abstract 1
- 229940112822 chewing gum Drugs 0.000 abstract 1
- 235000015218 chewing gum Nutrition 0.000 abstract 1
- 239000003086 colorant Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 abstract 1
- 229960004275 glycolic acid Drugs 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 229960000448 lactic acid Drugs 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 229940074096 monoolein Drugs 0.000 abstract 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 abstract 1
- 229960002969 oleic acid Drugs 0.000 abstract 1
- 235000021313 oleic acid Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 abstract 1
- 229960001860 salicylate Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) UNA CANTIDAD DE 10-80 w/w % DE GLUCOSA; B) 0.01-5 w/w% DE POR LO MENOS UN MEJORADOR DE ABSORCION SELECCIONADO ENTRE LECITINA, ACIDO HIALURONICO, ACIDO GLICOLICO, ACIDO LACTICO, EXTRACTO DE MANZANILLA, ACIDO OLEICO, MONOOLEINA, ALCALI METAL SALICILATO, ENTRE OTROS; C) UNA CANTIDAD EFECTIVA DE UN PORTADOR FARMACEUTICAMENTE ACEPTABLE SELECCIONADO ENTRE SABORIZANTES, COLORANTES, PRESERVANTES, ENTRE OTROS. DICHA COMPOSICION, DONDE EL PORTADOR ES A BASE DE GOMA DE MASCAR, ESTA LIBRE DE AGENTES FARMACEUTICOS ACTIVOS ADICIONALES SIENDO UTIL EN EL TRATAMIENTO DE HIPOGLICEMIAIT REFERS TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES: A) A QUANTITY OF 10-80 w / w% OF GLUCOSE; B) 0.01-5 w / w% OF AT LEAST ONE ABSORPTION ENHANCER SELECTED FROM LECITHIN, HYALURONIC ACID, GLYCOLIC ACID, LACTIC ACID, CHAMOMILE EXTRACT, OLEIC ACID, MONOOLEIN, ALKALI METAL SALICYLATE, BETWEEN; C) AN EFFECTIVE AMOUNT OF A PHARMACEUTICALLY ACCEPTABLE CARRIER SELECTED AMONG FLAVORS, COLORS, PRESERVATIVES, AMONG OTHERS. SAID COMPOSITION, WHERE THE CARRIER IS BASED ON CHEWING GUM, IS FREE OF ADDITIONAL ACTIVE PHARMACEUTICAL AGENTS, BEING USEFUL IN THE TREATMENT OF HYPOGLYCEMIA
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/544,530 US20080085331A1 (en) | 2006-10-06 | 2006-10-06 | Composition and method for raising blood glucose level |
| CA002562821A CA2562821A1 (en) | 2006-10-06 | 2006-10-06 | Composition and method for raising blood glucose level |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20080396A1 true PE20080396A1 (en) | 2008-06-06 |
Family
ID=41128097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000181A PE20080396A1 (en) | 2006-10-06 | 2007-02-19 | COMPOSITION AND METHOD TO RAISE GLUCOSE LEVEL IN BLOOD |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA2562821A1 (en) |
| PE (1) | PE20080396A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015187356A1 (en) * | 2014-06-04 | 2015-12-10 | Quick Joshua Ryan | System and method for delivering an inhalable sugar formulation |
-
2006
- 2006-10-06 CA CA002562821A patent/CA2562821A1/en not_active Abandoned
-
2007
- 2007-02-19 PE PE2007000181A patent/PE20080396A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2562821A1 (en) | 2008-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX349176B (en) | Transdermal drug delivery using an osmolyte and vasoactive agent. | |
| WO2008070368A3 (en) | Methods and compositions for skin care | |
| EP1852114A4 (en) | PREPARATION CONTAINING DIHOMO- (gamma) -LINOLENIC ACID (DGLA) AS ACTIVE INGREDIENT | |
| EP2444060A3 (en) | Composition | |
| CR9351A (en) | COMPOSITIONS AND METHODS FOR TOPICA APPLICATION AND TRANSDERMIC SUPPLY OF BOTULIN TOXIN | |
| AR057631A1 (en) | COMPOSITIONS AND METHODS TO INCREASE INSULIN SENSITIVITY | |
| UY29902A1 (en) | DIARILURES FOR THE TREATMENT OF PULMONARY HYPERTENSION | |
| ECSP077387A (en) | COMPOSITIONS CONTAINING PIPERACILIN, TAZOBACTAM AND AN AMINOCARBOXYL ACID IN A SODIUM LACTATE DILUENT | |
| PE20091715A1 (en) | STICKED IGF-I VARIANTS AND COMPOSITIONS CONTAINING THEM | |
| EA200501819A1 (en) | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR RELIABLE ACHIEVEMENT OF ACCEPTABLE TESTERTERON LEVELS IN SERUM | |
| PE20000860A1 (en) | ORAL MUCOADHESIVE COMPOSITIONS CONTAINING GASTROINTESTINAL ASSETS | |
| WO2009158625A3 (en) | Compositions and methods for treating or preventing gastrointestinal disorders and gerd-related respiratory disorders | |
| WO2007138466A3 (en) | Pharmaceutical compositions comprising meloxicam and tramadol combination | |
| RU2016135039A (en) | COMPOSITION FOR TREATMENT OF SURFACE DEFECTS | |
| WO2010033726A3 (en) | Drug delivery composition comprising a self-assembled gelator | |
| WO2008047061A3 (en) | Cosmetic oral and/or parenteral use of glucosamine optionally in combination with at least one polyphenol compound, and corresponding composition | |
| PE20060594A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING A PPAR AGONIST | |
| DE602006009259D1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING ORGANIC ORGANIC FUEL | |
| EP1742643A4 (en) | MODULATION OF GLUCOSE-6-PHOSPHATASE TRANSLOCASE EXPRESSION | |
| PE20061077A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING 7-TERBUTOXI-IMINO-METHYL-CAMPTOTECHIN | |
| WO2008087323A8 (en) | Galenic form for the transmucosal delivery of paracetamol | |
| PE20091235A1 (en) | COMPOSITIONS INCLUDING ASIAN ACID AND / OR MADECASIC ACID | |
| PE20080396A1 (en) | COMPOSITION AND METHOD TO RAISE GLUCOSE LEVEL IN BLOOD | |
| EA200701750A1 (en) | IMPROVED PENOFIBRATE COMPOSITIONS CONTAINING MENTHOL OR PEG / POLOXAMER | |
| IN2012DN00977A (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |